Drug Combination on Exercise Performance at High Altitude
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the effectiveness of using two FDA approved
medications in concert to reduce the likelihood of sickness due to low oxygen levels and to
reduce the decrement in physical performance at higher elevations. The investigators
hypothesize that this drug combination will reduce the symptoms of acute mountain sickness
and improve exercise performance at high altitude compared to placebo.